Connect with us
Oxford's Bundibugyo Ebola vaccine has entered a Uganda trial, but about 620,000 doses remain unused while Congo records 9,415 cases...
NICE has declined Roche's Itovebi for PIK3CA-mutated advanced breast cancer even after raising its cost bar, citing price, a trial mismatch and testing gaps.
Covid admissions ticked up in England while flu stayed at baseline, landing on A&E that already missed its four-hour mark and 75+ jab coverage of 23%.
Open enrollment is underway as 193 counties lose every general Medicare Advantage drug plan, and a 63-day Medigap window is easy to miss.
Arkansas cut 18,164 people in 2018, mostly over paperwork. CMS now budgets 1.3 million similar Medicaid losses when the 80-hour rule starts in 2027.
Former FDA chiefs say the 3,500 DOGE cuts left junior reviewers in sponsor meetings, a gap hiring has not closed even after Makary’s exit.
Hospitals sued in Maine to freeze a 340B rebate pilot that would make them pay wholesale first on 21 listed drugs.
Kenya's first Ebola death arrived on a commercial flight from Kampala. Bundibugyo has no licensed vaccine, and 108 contacts remain in quarantine.
A 1995 packaging threshold would cover chemicals added on purpose to food, using cancer-era math that hormone-disrupting doses can already beat.
The United States has confirmed 4,080 measles cases in 2026, only 18 of them in visitors, after kindergarten MMR coverage fell to 92.4%.
Kenya’s first Bundibugyo Ebola death is an imported DRC case. Licensed vaccines miss this species, and 122 contacts are now under watch.
